Skip to main content
SpringerLink
Log in

Prescription medication use during pregnancy and risk of infant leukemia (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: We explored whether maternal medication use during pregnancy may be an important etiologic area for investigation in studies of infant leukemia. Methods: In this case–control study, associations were explored between specific medications as recorded in the medical records of 243 mothers of infants who were diagnosed with leukemia at <18 months of age and 393 mothers of infants without leukemia identified through random digit dialing. Cases included 157 acute lymphoblastic (ALL), 77 acute myeloid (AML), and nine other leukemias. A total of 27 different drugs that were prescribed for at least six women were analyzed. Results: Overall, non-statistically significant negative associations (Odds ratios, OR < 0.5) were observed with amoxicillin, nystatin, clomiphene, levothyroxine, cefaclor, and trimethobenzamide HCL. When cases were restricted to either myeloid or lymphoblastic leukemia, cotrimoxazole was prescribed for five ALL case mothers and no matched controls; no association with cotrimoxazole was observed with AML. Conclusions: Given the number of comparisons, chance cannot be ruled out for any of the associations found here. However, a strength of this study is the lack of recall bias. The disparate data observed between AML and ALL in some instances may indicate areas of interest; they will be explored further in a case–control study of infant leukemia that is currently underway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lenz W, Knapp K (1962) Die Thalidomid-Embryopathie. Dtsch Med Wochenschr 87: 1232-1242.

    Google Scholar 

  2. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A (1995) Teratogenicity of high vitamin A intake. N Engl J Med 333: 1369-1373.

    Google Scholar 

  3. Herbst AL, Poskanzer DC, Robboy SJ, Frielander L, Scully RE (1975) Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 292: 334-339.

    Google Scholar 

  4. Stevenson RE, Allen WP, Pai GS, et al. (2000) Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106: 677-683.

    Google Scholar 

  5. Wiemels JL, Cazzaniga G, Daniotti M, et al. (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354: 1499-1503.

    Google Scholar 

  6. Ross JA, Davies SM, Potter JD, Robison LL (1994) Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 16: 243-272.

    Google Scholar 

  7. Shu XO, Reaman GH, Lampkin B, Sather HN, Pendergrass TW, Robison LL (1994) Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 3: 645-653.

    Google Scholar 

  8. Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol 145: 58-67.

    Google Scholar 

  9. Mertens AC, Wen W, Davies SM, et al. (1998) Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr 133: 617-623.

    Google Scholar 

  10. Wen WQ, Shu XO, Sellers T, Bhatia S, Lampkin B, Robison LL (1998) Family history of cancer and autoimmune disease and risk of leukemia in infancy: a report from the Children's Cancer Group (United States and Canada). Cancer Causes Control 9: 161-171.

    Google Scholar 

  11. Ross JA, Severson RK, Pollock BH, Robison LL (1996) Childhood cancerin the United States: a geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 77: 201-207.

    Google Scholar 

  12. Robison LL, Daigle AE (1984) Control selection using random digit dialing forcases of childhood cancer. Am J Epidemiol 120: 164-166.

    Google Scholar 

  13. Breslow NE, Day NE (1980) Statistical methods in cancer research, Vol. 1, The analysis of case-control studies. IARC scientific publication no. 32. Lyon: International Agency for Research on Cancer, pp. 5-338.

    Google Scholar 

  14. Lacy CF, Armstrong LL, Goldman MP, Lance LL (2001) Drug Information Handbook 2000-2001. Hudson, OH: Lexi-Comp Inc.

    Google Scholar 

  15. Principi N, Marchisio P, Biasini A, Dalla Villa A, Biasini G (1984) Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole). Acta Paediatr Scand 73: 763-767.

    Google Scholar 

  16. Bjornson BH, McIntrye AP, Harvey JM, Tauber AI (1986) Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis. Am J Hematol 23: 1-7.

    Google Scholar 

  17. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98: 4004-4009.

    Google Scholar 

  18. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358: 1935-1940.

    Google Scholar 

  19. Rustia M, Shubik P (1972) Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 48: 721-729.

    Google Scholar 

  20. Chacko M, Bhide SV (1986) Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice. J Cancer Res Clin Oncol 112: 135-140.

    Google Scholar 

  21. Thapa PB, Whitlock JA, Brockman Worrell KG, et al. (1998) Prenatal exposure to metronidazole and risk of childhood cancer. A retrospective cohort study of children younger than 5 years. Cancer 83: 1461-1468.

    Google Scholar 

  22. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT (2001) Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 12: 461-466.

    Google Scholar 

  23. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia: a report from the Children's Cancer Group. Cancer Causes Control 7: 581-590.

    Google Scholar 

  24. Alexander FE, Patheal SL, Biondi A, et al. (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61: 2542-2546.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics University of Minnesota, USA

    Julie A. Ross, Yang Xie, Stella M. Davies & Leslie L. Robison

  2. Center for Health Service Research, Vanderbilt University, USA

    Xiao-ou Shu

  3. Seattle Children's Hospital & Regional Medical Center, USA

    Thomas W. Pendergrass

Authors
  1. Julie A. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yang Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stella M. Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-ou Shu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas W. Pendergrass
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leslie L. Robison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie A. Ross.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, J.A., Xie, Y., Davies, S.M. et al. Prescription medication use during pregnancy and risk of infant leukemia (United States). Cancer Causes Control 14, 447–451 (2003). https://doi.org/10.1023/A:1024953532355

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024953532355

Search

Navigation